The India Cements (INDIACEM) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
18 Jun, 2026Executive summary
Cement demand remained steady, supported by increased government CapEx, with 2,108 km of highways built in Q1 FY26, up 8.9% year-over-year.
Domestic sales volume reached 2.18 MnT in Q1 FY26, marking an 11.6% year-over-year increase, with consolidated volume growth at 9.7% including Kesoram.
Urban housing showed signs of a future rebound, while rural markets continued to perform well.
EBITDA per metric ton rose sharply to ₹424 from ₹88 in Q4 FY25, and consolidated PBIDT for Q1 FY26 was Rs.92.31 crores, up from a loss of Rs.9.16 crores year-over-year.
Average capacity utilization stood at 61% for the quarter.
Financial highlights
Realizations for the UltraTech brand increased 2.2% sequentially; cement realizations (net of logistics cost) improved by 5.7% quarter-over-quarter.
Net sales for Q1 FY26 were ₹1,025 crore, nearly flat year-over-year.
EBITDA improved to ₹92 crore from a loss of ₹9 crore in Q1 FY25.
Finance costs reduced sharply to Rs.26.58 crores from Rs.82.36 crores year-over-year due to successful debt refinancing.
Average cost of borrowing was 7% for the previous quarter, with further reductions expected due to rate cuts.
Outlook and guidance
Double-digit volume growth targeted for FY26, with new capacities and integration of acquisitions supporting this goal.
CapEx for FY26 is close to INR 10,000 crores, with further guidance for FY27 to be provided later.
Planned capex for productivity and energy efficiency is expected to yield benefits starting Q4 FY27.
Green power (RE + WHRS) targeted to scale from 5% to 86% by FY27.
Profitability is expected to improve as capex benefits and synergies from the holding company materialize.
Latest events from The India Cements
- Record capacity, robust growth, higher dividends, and restructuring amid legal and cost headwinds.INDIACEM
Q4 25/2628 Apr 2026 - Sales up 25% YoY, revenue higher, but net losses persist amid cost and legal risks.INDIACEM
Q3 25/2613 Apr 2026 - Sales and EBITDA improved as expansion, brand transition, and restructuring progressed.INDIACEM
Q2 25/263 Feb 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Losses widened on lower revenue, with major asset sales and a pending UltraTech acquisition.INDIACEM
Q2 24/251 Sep 2025 - Q3 FY25 saw lower revenue, major losses, UltraTech's takeover, and large asset revaluation gains.INDIACEM
Q3 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025